NCT06231810 · Virginia Polytechnic Institute and State University
Tracking a Tactile Signal Along the Nervous System
What this study is about
Quantify the flow of a tactile signal from the stimulus at the finger at the peripheral nervous system (PNS), to the central nervous system (CNS), and to cognitive perception at the brain in young adults (Aim 1) and individuals with and without stroke (Aim 2).
View original scientific description
Quantify the flow of a tactile signal from the stimulus at the finger at the peripheral nervous system (PNS), to the central nervous system (CNS), and to cognitive perception at the brain in young adults (Aim 1) and individuals with and without stroke (Aim 2).
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- -right-hand dominance for participants who are neurotypical For Aim 1: -age range of 18-23 For Aim 2:
- participants who are neurotypical will be a similar age to the participants with stroke
- participants who are neurotypical will have no musculoskeletal and neurological conditions
- participants with stroke will have a single stroke incident resulting in a unilateral lesion (ischemic and hemorrhagic)
- participants with stroke will be in the chronic phase (\>1 year from stroke onset)
- participants with stroke will have an onset of stroke after the age of 18
- participants with stroke who meet the criteria of having the capacity to provide informed consent, regardless of aphasia
Exclusion criteria
- pregnant women
- adults not capable of consenting on their own behalf. For Aim 2:
- participants with stroke who have used antispastic injections in the past six months
- participants with stroke who have a lesion in the brainstem and/or cerebellum
- participants with stroke who have a stroke arising due to brain surgery
- participants with stroke who have hemineglect
Where
- Blacksburg, Virginia
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 17, 2026 · Source of record for eligibility and locations